Skip to main content
Top
Published in: Drugs 1/2019

Open Access 01-02-2019 | Hepatic Encephalopathy | Review Article

Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles

Author: Karin Weissenborn

Published in: Drugs | Special Issue 1/2019

Login to get access

Abstract

In general, hepatic encephalopathy (HE) is defined as a brain dysfunction caused by liver insufficiency and/or portal-systemic blood shunting. This article relates to the so-called type C HE: that is, HE in patients with liver cirrhosis. It manifests as a wide spectrum of neurological or psychiatric abnormalities, ranging from subclinical alterations, detectable only by neuropsychological or neurophysiological assessment, to coma. Several scales have been developed for grading the extent of HE. The most often used is the West Haven criteria (WHC), which differentiate between four grades of clinically overt HE. Patients with liver cirrhosis without clinically overt symptoms of HE but neuropsychological or neurophysiological findings indicating brain dysfunction are considered to have minimal hepatic encephalopathy (MHE). For simplification, some experts suggest differentiating between covert HE (MHE plus grade I HE according to WHC) and overt HE (WHC grades II–IV). Diagnosis of both MHE and overt HE is hampered by the fact that none of the symptoms of HE or the findings in the various diagnostic measures applied are specific. Thus, a diagnosis of HE or MHE can only be made after exclusion of other possible causes of brain dysfunction.
Literature
1.
go back to reference Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–35.CrossRefPubMed Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–35.CrossRefPubMed
2.
go back to reference Romero-Gómez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015;62(2):437–47.CrossRefPubMed Romero-Gómez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015;62(2):437–47.CrossRefPubMed
3.
go back to reference Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42(5):1158–65.CrossRefPubMed Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42(5):1158–65.CrossRefPubMed
4.
go back to reference Read A, Sherlock S, Laidlaw J, Walker JG. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med. 1967;36(114):135–50. Read A, Sherlock S, Laidlaw J, Walker JG. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med. 1967;36(114):135–50.
5.
go back to reference Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, et al. Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol. 2013;58(4):698–705.CrossRefPubMed Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, et al. Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol. 2013;58(4):698–705.CrossRefPubMed
6.
go back to reference Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768–73.CrossRefPubMed Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768–73.CrossRefPubMed
8.
go back to reference Weissenborn K. Diagnosis of minimal hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(Suppl 1):S54–9.CrossRefPubMed Weissenborn K. Diagnosis of minimal hepatic encephalopathy. J Clin Exp Hepatol. 2015;5(Suppl 1):S54–9.CrossRefPubMed
10.
go back to reference Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, et al. The animal naming test: an easy tool for the assessment of hepatic encephalopathy. Hepatology. 2017;66(1):198–208.CrossRefPubMed Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, et al. The animal naming test: an easy tool for the assessment of hepatic encephalopathy. Hepatology. 2017;66(1):198–208.CrossRefPubMed
11.
go back to reference Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, et al. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis. 2016;31(6):1217–29.CrossRefPubMed Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, et al. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis. 2016;31(6):1217–29.CrossRefPubMed
12.
go back to reference Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, et al. Covert hepatic encephalopathy: agreement and predictive validity of different indices. World J Gastroenterol. 2014;20(42):15756–62.CrossRefPubMedPubMedCentral Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, et al. Covert hepatic encephalopathy: agreement and predictive validity of different indices. World J Gastroenterol. 2014;20(42):15756–62.CrossRefPubMedPubMedCentral
13.
go back to reference Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55(8):2381–90.CrossRefPubMed Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55(8):2381–90.CrossRefPubMed
14.
go back to reference Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45(4):879–85.CrossRefPubMed Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45(4):879–85.CrossRefPubMed
15.
go back to reference Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, Afshar K, Rümke S, Barg-Hock H, et al. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut. 2013;62(10):1497–504.CrossRefPubMed Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, Afshar K, Rümke S, Barg-Hock H, et al. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut. 2013;62(10):1497–504.CrossRefPubMed
16.
go back to reference Montagnese S, Schiff S, Amodio P. Quick diagnosis of hepatic encephalopathy: fact or fiction? Hepatology. 2015;61(1):405–6.CrossRefPubMed Montagnese S, Schiff S, Amodio P. Quick diagnosis of hepatic encephalopathy: fact or fiction? Hepatology. 2015;61(1):405–6.CrossRefPubMed
17.
go back to reference Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res. 2015;40(2):265–73.CrossRefPubMed Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res. 2015;40(2):265–73.CrossRefPubMed
18.
go back to reference Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is “normal”? J Hepatol. 2017;66(4):825–35.CrossRefPubMed Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is “normal”? J Hepatol. 2017;66(4):825–35.CrossRefPubMed
19.
go back to reference Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, et al. Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology. 2003;124(2):346–51.CrossRefPubMed Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, et al. Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology. 2003;124(2):346–51.CrossRefPubMed
20.
go back to reference Zhang XD, Zhang LJ. Multimodal MR imaging in hepatic encephalopathy: state of the art. Metab Brain Dis. 2018;33(3):661–71.CrossRefPubMed Zhang XD, Zhang LJ. Multimodal MR imaging in hepatic encephalopathy: state of the art. Metab Brain Dis. 2018;33(3):661–71.CrossRefPubMed
22.
go back to reference Chen HJ, Chen R, Yang M, Teng GJ, Herskovits EH. Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining. AJNR Am J Neuroradiol. 2015;36(3):481–7.CrossRefPubMed Chen HJ, Chen R, Yang M, Teng GJ, Herskovits EH. Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining. AJNR Am J Neuroradiol. 2015;36(3):481–7.CrossRefPubMed
Metadata
Title
Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles
Author
Karin Weissenborn
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
Drugs / Issue Special Issue 1/2019
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-018-1018-z

Other articles of this Special Issue 1/2019

Drugs 1/2019 Go to the issue